SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis
NVS 126.31-0.2%12:16 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark H. Bornfeld who wrote ()2/1/1997 11:23:00 PM
From: AMF   of 296
 
Last week's edition of Barron's (Jan.27) had Part #3 of a stockpicker's roundtable. One of the analyst's, Oscar Schafer, chose Novartis as a "powerhouse" company that's "undervalued and underfollowed in the USA". Had other good things to say about new management and product line. Shafer said he picked Merck last year and it had a 30% increase...he thinks Novartis will do as well +++. Check it out at the Barrons website free. Hope this helps.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News